The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEssentra Regulatory News (ESNT)

Share Price Information for Essentra (ESNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 182.20
Bid: 182.40
Ask: 182.60
Change: 0.00 (0.00%)
Spread: 0.20 (0.11%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 182.20
ESNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital Markets Event

15 Nov 2022 07:00

RNS Number : 3744G
Essentra plc
15 November 2022

ESSENTRA PLC

Capital Markets Event

Accelerating our potential as a pure-play components business

Essentra PLC ("Essentra" or the "Company"), a leading global provider of essential components and solutions, is hosting a Capital Markets Event ("CME") for investors and analysts today.

The CME will be hosted by Scott Fawcett, Components MD and Group CEO designate, and Jack Clarke, CFO, together with a number of senior leaders from across the business, who will set out how Essentra's differentiated business model positions the Company for growth and market share gain.

The event will launch Essentra's strategy as a pure-play components business with the Company sharing its vision to be the world's leading responsible hassle-free supplier of essential industrial components, with the ambition of doubling revenue and tripling adjusted operating profits.

Medium-term financial targets:

Organic revenue >5% CAGR

Total revenue >10% CAGR

Adjusted operating margin c.18%

Net working capital to sales c.18%

Net debt to EBITDA

Supported by:

A clear strategy to drive market share gains, supported by a leading market position in a highly fragmented market

Margin expansion from scale, operating efficiencies, and pricing initiatives

A highly cash generative business with continued focus on working capital management

A strong financial framework and balance sheet to pursue value enhancing bolt-on M&A

Scott Fawcett, Components MD and Group CEO designate commented:

"Essentra has embarked on a journey of major transformation and we are excited to share the significant opportunity we have to accelerate our growth as a leading global manufacturer and distributor of industrial components.

We are well positioned to take market share and have a strong balance sheet to support investment and value enhancing bolt-on M&A. Sustainability and digitalisation will continue to be a source of competitive advantage as we look to expand our margins. I am confident our strategy will support the delivery of our medium-term financial targets and will drive significant long-term value for all of our stakeholders."

The Company will not give an update on current trading today.

The CME聽will start at 10:00am GMT and finish at approximately 12:30pm, at Peel Hunt LLP, 7th Floor, 100 Liverpool St,聽London聽EC2M 2AT. To attend in person please contact investorrelations@essentra.com

Anyone wishing to attend the live webcast is encouraged to register at least 15 minutes before it commences on the company website: https://www.essentraplc.com/en/investors/company-information/webcasts-and-presentations

The webcast recording and presentation will be made available on the Company's website later today.

Enquiries

Essentra plc

Claire Goodman, Group Investor Relations Manager

Jack Clarke, Chief Financial Officer

Tel: +44 (0)1908 359100

Tulchan Communications LLP

Olivia Peters

Lisa Jarrett-Kerr

Tel: +44 (0)20 7353 4200

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCFFFEELEESEEF
Date   Source Headline
3rd May 202411:32 amRNSTransaction in Own Shares
3rd May 202411:26 amRNSTransaction in Own Shares - Correction
3rd May 202411:17 amRNSTransaction in Own Shares - Correction
3rd May 202411:12 amRNSTransaction in Own Shares - Correction
3rd May 202411:06 amRNSTransaction in Own Shares - Correction
3rd May 202411:02 amRNSTransaction in Own Shares - Correction
3rd May 202410:58 amRNSTransaction in Own Shares - Correction
3rd May 202410:53 amRNSTransaction in Own Shares - Correction
3rd May 202410:46 amRNSTransaction in Own Shares - Correction
3rd May 202410:36 amRNSTransaction in Own Shares - Correction
3rd May 202410:26 amRNSTransaction in Own Shares
3rd May 202410:22 amRNSTransaction in Own Shares - Correction
3rd May 202410:06 amRNSTransaction in Own Shares - Correction
3rd May 20249:59 amRNSTransaction in Own Shares - Correction
3rd May 20249:54 amRNSTransaction in Own Shares - Correction
3rd May 20249:47 amRNSTransaction in Own Shares - Correction
3rd May 20249:30 amRNSTransaction in Own Shares - Correction
2nd May 20249:44 amRNSTransaction in Own Shares
1st May 20247:00 amRNSTotal Voting Rights
30th Apr 20247:45 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20241:57 pmRNSDirector/PDMR Shareholding
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20242:28 pmRNSDirector/PDMR Shareholding
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20241:35 pmRNSDirector/PDMR Shareholding
5th Apr 20241:35 pmRNSDirector/PDMR Shareholding
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20242:08 pmRNSDirector/PDMR Shareholding
4th Apr 202411:00 amRNSNotice of AGM
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 202411:26 amRNSTransaction in Own Shares
2nd Apr 20242:51 pmRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSTotal Voting Rights
28th Mar 20244:18 pmRNSPublication of 2023 Annual Report
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.